![[HTML version]](/e/graphics/htmlborder.gif)
![[PDF version]](/e/graphics/pdfborder.gif)
![[CIF]](/e/graphics/cifborder.gif)
![[3d view]](/e/graphics/3dviewborder.gif)
![[Structure Factors]](/e/graphics/structurefactorsborder.gif)
![[Supplementary Material]](/e/graphics/supplementarymaterialsborder.gif)
![[CIF check Report]](/e/graphics/checkcifborder.gif)
![[Buy article online]](/logos/buy.gif)
![[Contents scheme]](bg2052contents.gif)
Acta Cryst. (2007). E63, m1748-m1749 [ doi:10.1107/S1600536807023628 ]
-1,4-cyclohexanedicarboxylato-
2O,O'] monohydrate]Abstract: In the title compound, {[Cu(1,4-chdc)(L)2]·H2O}n, where 1,4-chdc is the 1,4-cyclohexanedicarboxylate dianion, C8H10O42-, and L is 2-methyl-1H-imidazole, C4H6N2, each CuII atom is four-coordinated by two N atoms from two L ligands and two O atoms from two 1,4-chdc anions in a distorted tetrahedral geometry. Each 1,4-chdc ligand bridges two neighbouring CuII atoms in a bidentate mode, forming a unique helical chain. These chains are decorated with L ligands alternately on the two sides. O-H
O and N-H
O hydrogen bonds complete the structure.
Online 26 May 2007
Copyright © International Union of Crystallography
IUCr Webmaster